Project
OCEAN
Aborted · 2023 until 2024
Bilz Stefan, Räss Andrea, Rickli Hans, Vetsch Susanne
Type
Clinical Studies
Range
Multicentric, KSSG as participating partner
Units
Status
Aborted
Start Date
2023
End Date
2024
Financing
Industry
Phase
III
Brief description/objective
A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Olpasiran on Major Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease and Elevated Lipoprotein (a).